A Symposium: Controversies in Thrombolytic TherapySMALLING, Richard W.The American journal of cardiology. 1996, Vol 78, Num 12A, issn 0002-9149, 29 p.Conference Proceedings

Prognostic markers in thrombolytic therapy : Looking beyond mortalityPEPINE, C. J.The American journal of cardiology. 1996, Vol 78, Num 12A, pp 24-27, issn 0002-9149Conference Paper

Patency trials with reteplase (r-PA) : What do they tell us ?BODE, C; NORDT, T. K; PETER, K et al.The American journal of cardiology. 1996, Vol 78, Num 12A, pp 16-19, issn 0002-9149Conference Paper

How much do we gain by reducing time to reperfusion therapy ?CALIFF, R. M; NEWBY, L. K.The American journal of cardiology. 1996, Vol 78, Num 12A, pp 8-15, issn 0002-9149Conference Paper

Clinical trials in thrombolytic therapy : What do they tell us ? INJECT 6-month outcomes dataWILCOX, R. G.The American journal of cardiology. 1996, Vol 78, Num 12A, pp 20-23, issn 0002-9149Conference Paper